Article info

Download PDFPDF

Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis
Free

Authors

  1. Correspondence to Dr Steven O'Reilly, Stipe Therapeutics, Aarhus, Denmark; SOR{at}stipetherapeutics.com
View Full Text

Citation

Distler JHW, O'Reilly S
Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis

Publication history

  • Received October 21, 2021
  • Accepted November 12, 2021
  • First published November 29, 2021.
Online issue publication 
January 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.